Cargando…

Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes

The tumor microenvironment has recently emerged as a critical component of high-grade serous ovarian cancer (HGSC) disease progression. Specifically, cancer-associated fibroblasts (CAFs) have been recognized as key players in various pro-oncogenic processes. Here, we use mass-spectrometry (MS) to ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Govindarajan, Meinusha, Ignatchenko, Vladimir, Ailles, Laurie, Kislinger, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855416/ https://www.ncbi.nlm.nih.gov/pubmed/36671461 http://dx.doi.org/10.3390/biom13010075

Ejemplares similares

High-throughput approaches for precision medicine in high-grade serous ovarian cancer
por: Govindarajan, Meinusha, et al.
Publicado: (2020)

Glycoproteomics Identifies Plexin-B3 as a Targetable Cell Surface Protein Required for the Growth and Invasion of Triple-Negative Breast Cancer Cells
por: Kuhlmann, Laura, et al.
Publicado: (2022)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

Modeling the Role of Cancer-Associated Fibroblasts in Tumor Cell Invasion
por: Poon, Stephanie, et al.
Publicado: (2022)

Cell-Surface Proteomics Identifies Lineage-Specific Markers of Embryo-Derived Stem Cells
por: Rugg-Gunn, Peter J., et al.
Publicado: (2012)

Detecting protein variants by mass spectrometry: a comprehensive study in cancer cell-lines
por: Alfaro, Javier A., et al.
Publicado: (2017)

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
por: Kim, Yunee, et al.
Publicado: (2016)

Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer
por: Si, Manfei, et al.
Publicado: (2019)

WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells
por: Yu, Hai-Lan, et al.
Publicado: (2019)

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer
por: Tomar, Tushar, et al.
Publicado: (2017)

Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer
por: Arentz, Georgia, et al.
Publicado: (2023)

Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes
por: Thomas, Stefani N., et al.
Publicado: (2020)

Convergence of Plasma Metabolomics and Proteomics Analysis to Discover Signatures of High-Grade Serous Ovarian Cancer
por: Ahn, Hee-Sung, et al.
Publicado: (2020)

Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review
por: Bradbury, Melissa, et al.
Publicado: (2021)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

ZIP4 Is a Novel Cancer Stem Cell Marker in High-Grade Serous Ovarian Cancer
por: Fan, Qipeng, et al.
Publicado: (2020)

Single-Cell Proteomics Analysis of Recurrent Low-Grade Serous Ovarian Carcinoma and Associated Brain Metastases
por: Pejovic, Tanja, et al.
Publicado: (2022)

Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
por: Xie, Hongyu, et al.
Publicado: (2017)

Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer
por: Xiang, Li, et al.
Publicado: (2018)

Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
por: Criscuolo, Daniela, et al.
Publicado: (2022)

Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging
por: Kulbe, Hagen, et al.
Publicado: (2020)

A proteomic investigation of isogenic radiation resistant prostate cancer cell lines
por: Kurganovs, Natalie, et al.
Publicado: (2021)

NotI Microarrays: Novel Epigenetic Markers for Early Detection and Prognosis of High Grade Serous Ovarian Cancer
por: Kashuba, Vladimir, et al.
Publicado: (2012)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer
por: Li, Min, et al.
Publicado: (2020)

CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
por: Wheeler, Lindsay J., et al.
Publicado: (2018)

BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling
por: Bradbury, Melissa, et al.
Publicado: (2022)

The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012)

Principles of dormancy evident in high-grade serous ovarian cancer
por: Shepherd, Trevor G., et al.
Publicado: (2022)

Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers
por: Azzalini, Eros, et al.
Publicado: (2023)

Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
por: Topno, Rachel, et al.
Publicado: (2021)

Markers of T Cell Infiltration and Function Associate with Favorable Outcome in Vascularized High-Grade Serous Ovarian Carcinoma
por: Townsend, Katelin N., et al.
Publicado: (2013)

Machine Learning analysis of high-grade serous ovarian cancer proteomic dataset reveals novel candidate biomarkers
por: Farinella, Federica, et al.
Publicado: (2022)

Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior
por: Reyes, Henry D., et al.
Publicado: (2019)

VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
por: Zong, Liju, et al.
Publicado: (2019)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma
por: Li, Yimin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l4slv4jelph912m45h04o83s1o